306 studies found for:    Amyotrophic Lateral Sclerosis (ALS)
Show Display Options
Rank Status Study
21 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
22 Unknown  Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Olanzapine
23 Unknown  Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: Intramuscular diaphragm electrodes
24 Completed Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: KNS-760704;   Drug: Placebo
25 Completed Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
Conditions: Sialorrhea;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Botox injection;   Drug: Placebo injection
26 Enrolling by invitation Biological Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Biological: Cell-based therapeutics;   Other: Symptomatic treatment of ALS
27 Recruiting Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: Non-invasive home ventilation
28 Not yet recruiting Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Other: ALS Functional rating Scale-revised (ALS FRS-R);   Other: slow vital capacity;   Other: Blood sample;   Other: Cerebrospinal Fluid (CSF) sample
29 Unknown  Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Anakinra
30 Completed Amyotrophic Lateral Sclerosis (ALS) Gulf War Study
Condition: Amyotrophic Lateral Sclerosis
Intervention:
31 Active, not recruiting Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients
Conditions: ALS (Amyotrophic Lateral Sclerosis);   Iron Overload
Intervention: Drug: Deferiprone
32 Recruiting Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
Condition: Amyotrophic Lateral Sclerosis
Intervention:
33 Recruiting Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: MRI + 18FDG-PET + neuropsychological assessments ; 18FDG performed especially for the research
34 Not yet recruiting HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Raltegravir;   Drug: Zidovudine
35 Active, not recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF
36 Unknown  A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: lithium carbonate
37 Active, not recruiting Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Resistance Exercise;   Other: Endurance Exercise;   Other: Stretching/Range-of-Motion
38 Active, not recruiting A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: E0302 (mecobalamin)
39 Completed Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
Condition: Amyotrophic Lateral Sclerosis
Intervention: Behavioral: ALS Registry
40 Completed Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Ozanezumab;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years